Cytotoxic and cytostatic effects of anti-Thy 1.2 targeted doxorubicin and cyclosporin A
- 31 July 1996
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 40 (3) , 303-319
- https://doi.org/10.1016/0168-3659(95)00198-0
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- NF-ATp: a transcription factor required for the co-ordinate induction of several cytokine genesImmunology Today, 1994
- Design and tumor targeting of anthracyclines able to overcome multidrug resistance: A double-advantage approachPharmacology & Therapeutics, 1993
- Synthesis of 2'-deoxyuridine and 5-fluoro-2'-deoxyuridine derivatives and evaluation in antibody targeting studiesJournal of Medicinal Chemistry, 1993
- Analysis of a conjugate between anti-carcinoembryonic antigen monoclonal antibody and alkaline phosphatase for specific activation of the prodrug etoposide phosphateCancer Immunology, Immunotherapy, 1992
- Drug-polymer conjugatesAnti-Cancer Drugs, 1992
- Antibody-targeted cyclosporin AJournal of Controlled Release, 1992
- Targetable Polymeric Anticancer DrugsAnnals of the New York Academy of Sciences, 1991
- Selectivity of Antibody-Targeted Anthracycline Antibiotics on T LymphocytesJournal of Bioactive and Compatible Polymers, 1990
- Antibody-directed affinity therapy applied to the immune system: In vivo effectiveness and limited toxicity of daunomycin conjugated to HPMA copolymers and targeting antibodyClinical Immunology and Immunopathology, 1988
- Biological properties of targetable poly[N-(2-hydroxypropyl)-methacrylamide]-antibody conjugatesJournal of Controlled Release, 1985